Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Non-cash Items (2016 - 2018)

Vanda Pharmaceuticals' Non-cash Items history spans 9 years, with the latest figure at $28.6 million for Q1 2018.

  • For Q1 2018, Non-cash Items rose 738.3% year-over-year to $28.6 million; the TTM value through Mar 2018 reached $28.6 million, up 738.3%, while the annual FY2017 figure was $24.4 million, 513.13% up from the prior year.
  • Non-cash Items for Q1 2018 was $28.6 million at Vanda Pharmaceuticals, up from $24.4 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $3.3 billion in Q2 2017 and bottomed at $198148.0 in Q2 2015.
  • The 5-year median for Non-cash Items is $15.0 million (2015), against an average of $209.8 million.
  • The largest annual shift saw Non-cash Items tumbled 99.43% in 2015 before it surged 27679.78% in 2017.
  • A 5-year view of Non-cash Items shows it stood at $28.5 million in 2014, then crashed by 73.71% to $7.5 million in 2015, then surged by 332.82% to $32.5 million in 2016, then dropped by 24.75% to $24.4 million in 2017, then increased by 17.06% to $28.6 million in 2018.
  • Per Business Quant, the three most recent readings for VNDA's Non-cash Items are $28.6 million (Q1 2018), $24.4 million (Q4 2017), and $8.6 million (Q3 2017).